Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 8/20 | 0.71 |
| ▸ | CASP2 | P42575 | 1/20 | 0.65 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.61 |
| ▸ | NAAA | Q02083 | 1/20 | 0.61 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.61 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.58 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.56 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.55 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29194353 | 1.00 | FAAH (0.71) | FAAHCASP2FFAR4NAAAFFAR1 | |
| SCHEMBL3124365 | 1.00 | FAAH (0.71) | FAAHCASP2FFAR4NAAAFFAR1 | |
| SCHEMBL29194363 | 1.00 | FAAH (0.71) | FAAHCASP2FFAR4NAAAFFAR1 | |
| SCHEMBL1289184 | 1.00 | FAAH (0.71) | FAAHCASP2FFAR4NAAAFFAR1 | |
| SCHEMBL3809725 | 1.00 | FAAH (0.71) | FAAHCASP2FFAR4NAAAFFAR1 | |
| SCHEMBL29194344 | 1.00 | FAAH (0.71) | FAAHCASP2FFAR4NAAAFFAR1 | |
| SCHEMBL2798993 | 1.00 | FAAH (0.71) | FAAHCASP2FFAR4NAAAFFAR1 | |
| SCHEMBL19066845 | 1.00 | FAAH (0.71) | FAAHCASP2FFAR4NAAAFFAR1 | |
| SCHEMBL342717 | 1.00 | FAAH (0.71) | FAAHCASP2FFAR4NAAAFFAR1 | |
| SCHEMBL7755826 | 1.00 | FAAH (0.71) | FAAHCASP2FFAR4NAAAFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117712476-A | Gel quasi-solid electrolyte and lithium battery prepared from same | 湖南大学 | 2024-03-15 | — | — | CN | claimed |
| CN-117712476-A | Gel quasi-solid electrolyte and lithium battery prepared from same | 湖南大学 | 2024-03-15 | — | — | CN | disclosed |
| US-20100216744-A1 | THICKENER/GELLANT FOR OILY SUBSTANCE | MIZUTANI GENZO | 2010-08-26 | — | — | US | disclosed |
| EP-2208769-A1 | THICKENER/GELLANT FOR OILY SUBSTANCE | Mizutani, Genzo (JP) | 2010-07-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100216744-A1 | THICKENER/GELLANT FOR OILY SUBSTANCE | GPR55, MKI67, SLC43A1 | FAAH 201/4885CASP2 4797/4885FFAR4 513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.